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Introduction
Although long distance organelle transport is generally
attributed to microtubule-based motors, growing evidence
indicates that actin-based motors, particularly the class V
myosins, also play crucial roles in membrane trafficking
(Brown, 1999; Reck-Peterson et al., 2000). The class V
myosins have been widely hypothesized to provide a molecular
basis for actin-dependent organelle transport (DePina and
Langford, 1999; Tuxworth and Titus, 2000). Class V myosins
are one of the most ancient groups of the myosin superfamily
(Berg et al., 2001) and are essential for survival in both yeast
(Johnston et al., 1991) and mouse (Mercer et al., 1991). Two
of the five myosins in yeast are class V myosins, and one of
these, Myo2p, is required for polarized secretion (Johnston et
al., 1991; Schott et al., 1999). In vertebrates, most research on
class V myosins has focused on myosin-Va (dilute, Myo5a),
which is expressed at high levels chiefly in brain and
melanocytes. Mice lacking Myo5a suffer neurological seizures
and die within 2-3 weeks of birth (Mercer et al., 1991); these
animals also exhibit serious defects in the distribution and
trafficking of melanosomes (Provance et al., 1996; Wu et al.,
1998). A second member of the myosin-V family in
vertebrates, myosin-Vb (myr6, Myo5b), has been cloned from
rat (Zhao et al., 1996), but has received relatively little
attention. Given the fundamental importance of class V
myosins in lower organisms and crucial role of Myo5a in brain
and melanocytes, we sought to identify a novel member of the
myosin-V family that might underlie actin-dependent organelle
transport in the other cells and tissues of the human body. 
Much of the evidence supporting the role of class V myosins
in organelle or particle transport comes from studies in yeast.
The yeast class V myosin Myo2p is required for polarized
secretion (Schott et al., 1999), vacuolar inheritance (Catlett et
al., 2000), Golgi inheritance (Rossanese et al., 2001) and
spindle orientation (Yin et al., 2000). The other class V myosin
in yeast, Myo4p, is required for the localization of an mRNA
to the bud (Takizawa and Vale, 2000). In squid, myosin-V has
been implicated in the movement of endoplasmic reticulum
(ER)-derived vesicles in the axon (Tabb et al., 1998). In
vertebrates, Myo5a is required for the transport/targeting of an
ER-derived Ca2+ release compartment to dendritic spines
(Takagishi et al., 1996) and the transport of melanosomes in
the actin-rich periphery of melanocytes (Rogers et al., 1999;
Wu et al., 1998). Myo5a also associates with SV2-labeled
vesicles from brain (Evans et al., 1998).
Although the membrane trafficking pathways of eukaryotic
cells are not yet fully understood, the rab family of small
GTPases are essential components of these pathways and
provide a useful set of molecular markers to define specific
membrane compartments (Zerial and McBride, 2001). Each of
the 60+ rab proteins in humans is believed to function at a
specific step in membrane trafficking (Bock et al., 2001).
Despite the essential roles of rab proteins in membrane
trafficking, much remains to be learned about their
mechanisms of action and the identity of their effectors.
Intriguingly, several recent studies indicate that certain rabs
may interact directly or indirectly with class V myosins in
vesicle transport. In yeast, Myo2p and the rab protein Sec4p
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Class V myosins are one of the most ancient and widely
distributed groups of the myosin superfamily and are
hypothesized to function as motors for actin-dependent
organelle transport. We report the discovery and initial
characterization of a novel member of this family, human
myosin-Vc (Myo5c). The Myo5c protein sequence shares
~50% overall identity with the two other class V myosins
in vertebrates, myosin-Va (Myo5a) and myosin-Vb
(Myo5b). Systematic analysis of the mRNA and protein
distribution of these myosins indicates that Myo5a is most
abundant in brain, whereas Myo5b and Myo5c are
expressed chiefly in non-neuronal tissues. Myo5c is
particularly abundant in epithelial and glandular tissues
including pancreas, prostate, mammary, stomach, colon
and lung. Immunolocalization in colon and exocrine
pancreas indicates that Myo5c is expressed chiefly in
epithelial cells. A dominant negative approach using a
GFP-Myo5c tail construct in HeLa cells reveals that the
Myo5c tail selectively colocalizes with and perturbs a
membrane compartment containing the transferrin
receptor and rab8. Transferrin also accumulates in this
compartment, suggesting that Myo5c is involved in
transferrin trafficking. As a class V myosin of epithelial
cells, Myo5c is likely to power actin-based membrane
trafficking in many physiologically crucial tissues of the
human body.
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exhibit genetic interactions such as synthetic lethality and have
been hypothesized to be components of a motor-rab transport
complex required for secretory vesicle transport (Finger and
Novick, 1998; Schott et al., 1999). In melanocytes, Myo5a and
rab27a are both required for normal melanosome trafficking
and Myo5a appears to require rab27a to dock to melanosomes
(Hume et al., 2001; Wu et al., 2001). Although biochemical
evidence for a direct interaction between class V myosins and
rab proteins has been difficult to obtain, recent two-hybrid data
indicate that Myo5b binds specifically and directly to rab11a
(Lapierre et al., 2001), a marker for a recycling compartment. 
We report the discovery and cloning of a third member of
the myosin-V family in vertebrates, human myosin-Vc
(Myo5c). This myosin is relatively abundant in many secretory
and glandular tissues, where it is expressed chiefly in epithelial
cells. To investigate the function of Myo5c, we have pursued
a dominant negative approach in a well-studied model of
membrane trafficking, the HeLa cell. Dominant negative
approaches using overexpression of the tail domain (the
putative cargo interaction site) have proven very successful in
investigating the functions of class V myosins in yeast,
melanocytes and even in brain, where the flailer mutation leads
to a brain-specific overexpression of the tail domain, resulting
in neurological defects (Jones et al., 2000). Recently, a GFP-
Myo5b tail construct was shown to selectively perturb the
distribution of a recycling compartment in HeLa cells defined
by the presence of the GFP-Myo5b tail, transferrin receptor
and rab11a (Lapierre et al., 2001). We report that
overexpression of a GFP-Myo5c tail selectively perturbs the
distribution of an apparently different compartment in HeLa
cells defined by the presence of GFP-Myo5c tail, transferrin
receptor and rab8. Overexpressing the GFP-Myo5c tail also
perturbs transferrin trafficking. We conclude that Myo5c is an
actin-based motor protein involved in membrane trafficking
and that Myo5c is a major class V myosin of epithelial cells. 
Materials and Methods 
Isolation and sequence analysis of MYO5c cDNA clones
Clones 2, 5 and 7 were amplified from Marathon Race Ready human
pancreas cDNA (Clontech) and subcloned into pCR 2.1 TOPO
(Invitrogen). Clone 7 was amplified using primers designed to a ~100
bp PCR product isolated from a previous screen for unconventional
myosins (Bement et al., 1994) and an expressed sequence tag (EST)
(T11378) that was similar but not identical to the tails of Myo5a and
Myo5b. Repeated attempts to clone the 5′ nd of the coding sequence
succeeded only after a genomic clone (AC010674.7) containing the
Myo5c sequence allowed us to PCR from putative 5′UTR into the
known coding sequence (clone 5). The coding sequence of clone 7
was found to be interrupted at bp 3645 by a 137 bp insert containing
an Alu-like sequence. Comparison with genomic sequence and PCR
with primers designed to span this region (Clone 2) verified that this
insert was in fact an intron that is normally spliced out of the mature
mRNA. PCR from a different cDNA library to produce the GFP-
Myo5c tail clone confirmed that this intron is normally spliced out.
All clones and PCR constructs were validated by sequencing at the
UNC-Chapel Hill Automated DNA Sequencing Facility.
mRNA expression analysis 
To perform systematic analysis of the mRNA distribution of each class
V myosin, 32P-labeled cDNA probes for Myo5a, Myo5b or Myo5c
were hybridized to a Human Multiple Tissue Northern Blot and a
Human RNA Master Blot (Clontech). Each lane of the Northern
Blot contained 2 µg of poly A+ RNA, whereas the Master Blot
contained normalized loadings of 89-514 ng of poly A+ RNA per dot.
Probes were labeled by random-priming and unbound counts were
removed using spin columns. Blots were hybridized (2-4×106
cpm/ml) and washed under high stringency conditions and exposed
for 24 hours by autoradiography or phosphorimager. Blots were
stripped and rehybridized under the same conditions with each probe.
Human cDNA probes consisted of a portion of the carboxy-terminal
tail and 3′ UTR and were amplified by PCR from the following ESTs:
the 669 bp Myo5a probe, spanning the terminal 169 bp of the tail and
he first 500 bp of the 3′ UTR, was amplified from EST N44526,
corresponding to human Myo5A, GenBank accession #Y07759. The
646 bp human Myo5b probe, spanning the terminal 452 bp of the
putative tail and the first 194 bp of the 3′ UTR, was amplified from
EST W40522, of which the coding sequence shares ~88% nucleotide
identity with rat Myo5b (myr6) and murine Myo5b. The 680 bp
Myo5c probe, spanning the terminal 141 bp of the tail and the first
539 bp of the 3′ UTR, was amplified from EST 178419. To facilitate
comparison of the dot blots, Adobe Photoshop was used to cut and
paste the dot blots into the strips shown in Fig. 3.
Production of affinity-purified antibodies to Myo5b and Myo5c 
Antibodies to mouse Myo5b and human Myo5c were raised against
His-tagged fusion proteins. The Myo5b tail construct was amplified
from a Marathon mouse kidney cDNA library (Clontech) and
consists of part of the tail domain of a partial mouse Myo5b sequence
(NM_008661; bp 341-1024), corresponding to amino acids (aa)
1209-1437 of rat myr6 (U60416). The Myo5c tail construct was
amplified from a human bronchial epithelial cell cDNA library and
consists of part of the tail domain (aa 1054-1350). The forward
primers for each construct contained a BamHI restriction site at their
5′ end, whereas the reverse primers contained a SalI restriction site
at their 5′ end. Each construct was cloned into pQE-30 or pQE-31
expression vectors (Qiagen). The bacterially expressed His-tagged
fusion proteins were purified by elution from an SDS-polyacrylamide
gel and injected into chickens (for Myo5b, Aves Labs, antibody
1962) or rabbits (for Myo5c, Covance, antibodies 199 and 200), and
the antibodies were affinity-purified on CNBr activated Sepharose 4B
columns coupled to the His-tagged fusion proteins used to generate
them. Although immunoblots indicate that the Myo5b antibody
reacts well with mouse Myo5b, it does not react well with human
Myo5b. The rabbit anti-Myo5a antibody used in this study (32a) was
generated against the tail and has been previously characterized
(Espreafico et al., 1992).
Construction and expression of the GFP-Myo5c tail
The Myo5c tail construct was amplified from a human bronchial
epithelial cell cDNA library (forward primer: 5′ GAACAAAGA-
AAACCATGGGCTGGT-3′; reverse primer: 5′-CTGCTATAACCT-
ATTCAGAAAGCCTA-3′) and was directionally cloned into pEGFP-
C2 (Clontech) at the XhoI restriction site (5′ end) and the BamHI
restriction site (3′ end). The resulting fusion protein consists of GFP
at the N-terminus followed by the entire tail of Myo5c (aa 902-1742).
Cultured cells were transfected using Polyfect (Qiagen) with a DNA
concentration of 0.625 µg/ml and fixed for immunofluorescence 12-
24 hours later.
Immunoblots
Cultured cells (isolated by scraping) or mouse tissues were
homogenized in 10 volumes of ice-cold TBS containing 2 mM EDTA,
2 mM DTT and 1 mM Pefabloc-SC. Homogenates were then
immediately mixed with SDS sample buffer and boiled. Between ~20
and 50 µg protein was loaded and samples were separated on 4-20%
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Fig. 1.Discovery and cloning of a novel class V myosin. (A) cDNA clones comprising the full coding sequence of human MYO5C. Combining
the sequence of clones 2, 5 and 7 and EST 178419 results in 6839 bp of cDNA including 19 bp of 5′UTR, 5229 bp of coding sequence and
1591 bp of 3′UTR containing an Alu repeat and ending in a poly-A tail. Black shading indicates the sequenced portion of the clones. The
locations of the mRNA probe, the His-tagged tail construct used to generate antibodies 199 and 200, and the GFP-tail construct re also
depicted. Arrows indicate PCR primers used for amplification. (B) The three class V myosins in vertebrates. Note that the Myo5c tail lacks a
PEST region but contains a small region similar to the alternatively spliced exon D mapped in Myo5a (Seperack et al., 1995). The human
Myo5a sequence used here consists of a GenBank sequence (Y07759) into which we have inserted the 25 aa sequence of exon F. This Myo5a
sequence thus includes all three alternatively spliced exons and will differ somewhat from actual splice forms in size and numberi g. The
diagrams of Myo5b and Myo5c are based on GenBank sequences U60416 and AF272390, respectively. (C) Predicted structure of the three
class V myosins. Interestingly, the length of the initial segment of coiled-coil is predicted to be ~30 nm for all three myosins.
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Tris-glycine SDS-PAGE gels. Gels were transferred to nitrocellulose
at 150 V-hours in transfer buffer (25 mM Tris, 192 mM glycine, 20%
methanol, 0.02% SDS). Affinity purified antibodies were used at 1-2
µg/ml with 1:100,000 HRP-conjugated donkey anti-rabbit (Jackson
Immunoresearch Laboratories, Inc.) or 1:1500 HRP-conjugated
donkey anti-chicken (Jackson) secondary antibodies. Immunoblots
were developed using SuperSignal West Pico ECL Substrate (Pierce)
and films were scanned and imaged using Adobe Photoshop.







Exon A Exon B Exon C
Exon E Exon F
globular tail
Myo5a construct that binds the dynein light chain
vacuole binding site in myo2p
* * * *mouse Myo5a construct that binds kinesin
Hum Myo5a  MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY HLDPKTKELP HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI   110
Rat Myo5b  MTYSELYSRY TRVWIPDPDE VWRSAELTKD YKDGDESLQL RLEDDTILDY PIDVQNNQVP FLRNPDILVG ENDLTALSHL HEPAVLHNLK VRFLESNHIY TYCGIVLVAI   110
Hum Myo5c  MAVAELYTQY NRVWIPDPEE VWKSAEIAKD YRVGDKVLRL LLEDGTELDY SVNPES..LP PLRNPDILVG ENDLTALSYL HEPAVLHNLR IRFAESKLIY TYSGIILVAM   108
Hum Myo5a  NPYEQLPIYG EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF ATVSGSASEA NVEEKVLTSN PIMESIGNAK TTRNDNSSRF   220
Rat Myo5b  NPYEQLPIYG QDVIYAYSGQ NMGDMDPHIF AVAEEAYKQM ARDEKNQSII VSGESGAGKT VSAKYAMRYF ATVGGSASDT NIEEKVLASS PIMEAIGNAK TTRNDNSSRF   220
Hum Myo5c  NPYKQLPIYG DAIIHAYSGQ NMGDMDPHIF AVAEEAYKQM ARNNRNQSII VSGESGAGKT VSARYAMRYF ATVSKSGSNA HVEDKVLASN PITEAVGNAK TTRNDNSSRF   218
Hum Myo5a  GKYIEIGFDK RYRIIGANMR TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADNFNYTKQ GGSPVIEGVD DAKEMAHTRQ ACTLLGISES HQMGIFRILA   330
Rat Myo5b  GKYIEIGFDK KYHIIGANMR TYLLEKSRVV FQADDERNYH IFYQLCAAAS LPEFKELALT CAEDFFYTAH GGNTTIEGVD DAEDFEKTRQ ALTLLGVRES HQISIFKIIA   330
Hum Myo5c  GKYTEISFDE QNQIIGANMS TYLLEKSRVV FQSENERNYH IFYQLCASAQ QSEFKHLKLG SAEEFNYTRM GGNTVIEGVN DRAEMVETQK TFTLLGFKED FQMDVFKILA   328
Hum Myo5a  GILHLGNVGF .TSRDADSCT IPPKHEPLCI FCDLMGVDYE EMCHWLCHRK LATATETYIK PISKLQATNA RDALAKHIYA KLFNWIVDNV NQALHSAVKQ HSFIGVLDIY   439
Rat Myo5b  SILHLGSVEI QAERDGDSCS ISPQDEHLSN FCRLLGIEHS QMEHWLCHRK LVTTSETYVK TMSLQQVVNA RNALAKHIYA QLFSWIVEHI NKALQTSLKQ HSFIGVLDIY   440
Hum Myo5c  AILHLGNVQI TAVGNERS.S VSEDDSHLKV FCELLGLESG RVAQWLCNRK IVTSSETVVK PMTRPQAVNA RDALAKKIYA HLFDFIVERI NQALQFSGKQ HTFIGVLDIY   437
Hum Myo5a  GFETFEINSF EQFCINYANE KLQQQFNMHV FKLEQEEYMK EQIPWTLIDF YDNQPCINLI ESKLGILDLL DEECKMPKGT DDTWAQKLYN THLNKCALFE KPRLSNKAFI   549
Rat Myo5b  GFETFEINSF EQFCINYANE KLQQQFNSHV FKLEQEEYMK EQIPWTLIDF YDNQPCIDLI EAKLGILDLL DEECKVPKGT DQNWAQKLYE RHSNS.QHFQ KPRMSNTAFI   549
Hum Myo5a  GFETFDVNSF EQFCINYANE KLQQQFNMHV FKLEQEEYMK EDIPWTLIDF YDNQPVIDLI EAKMGILELL DEECLLPHGT DENWPQKLYN NFVNRNPLFE KPRMSNTSFV   547
Hum Myo5a  IQHFADKVEY QCEGFLEKNK DTVFEEQIKV LKSSKFKMLP ELFQDDEKAI SPTSATSSGR TPLTRTPAKP TKGRPGQMAK EHKKTVGHQF RNSLHLLMET LNATTPHYVR   659
Rat Myo5b  VIHFADKVEY LSDGFLEKNR DTVYEEQINI LKASKFPLVA DLFRDDEDSV .PATNTAKSR SS.SKINVRS SRPLMKAPNK EHKKSVGYQF RTSLNLLMET LNATTPHYVR   657
Hum Myo5c  IQHFADKVEY KCEGFLEKNR DTVYDMLVEI LRASKFHLCA NFFQEN.... .PTPPSPFG. ...SMITVKS AKQVIKPNSK HFRTTVGSKF RSSLYLLMET LNATTPHYVR   648
Hum Myo5a  CIKPNDFKLP FTFDEKRAVQ QLRACGVLET IRISAAGFPS RWTYQEFFSR YRVLMKQKDV ..LSDRKQTC KNVLEKLILD KDKYQFGKTK IFFRAGQVAY LEKLRADKLR   767
Rat Myo5b  CIKPNDEKLP FHFDPKRAVQ QLRACGVLET IRISAAGYPS RWTYHDFFNR YRVLMKKREL ANTTDKKNIC KSVLESLIKD PDKFQFGRTK IFFRAGQVAY LEKLRADKFR   767
Hum Myo5c  CIKPNDEKLP FEFDSKRIVQ QLRACGVLET IRISAQSYPS RWTYIEFYSR YGILMTKQEL .SFSDKKEVC KVVLHRLIQD SNQYQFGKTK IFFRAGQVAY LEKLRLDKLR   757
Hum Myo5a  AACIRIQKTI RGWLLRKKYL RMRKAAITMQ RYVRGYQARC YAKF...LRR TKAATIIQKY WRMYVVRRRY KIRRAATIVL QSYLRGFLAR NRYRKILRGH KAVIIQKRVR   874
Rat Myo5b  EATIMIQKTV RGWLQRVKYR RLRAATLTLQ RFCRGYLARR LTEH...LRR TRAAIVFQKQ YRMLKARRAY CRVRRAAVII QSYTRGHVCT QKLPPVLTEH KATIIQKYAR   874
Hum Myo5c  QSCVMVQKHM RGWLQRKKFL RERRAALIIQ QYFRGQQTVR KAITAVALKE AWAAIIIQKH CRGYLVRSLY QLIRMATITM QAYSRGFLAR RRYRKMLEEH KAVILQKYAR   867
Hum Myo5a  GWLARTHYKR SMHAIIYLQC CFRRMMAKRE LKKLKIEARS VERYKKLRIG MENKIMQLQR KVDEQNKDYK CLVEKLTNLE GIYNSETEKL RSDLERLQLS EEEAKVATGR   984
Rat Myo5b  GWMARRHFQR QRDAAIVIQC AFRRLKARQA LKALKIEARS AEHLKRLNVG MENKVVQLQR KIDDQNKEFK TLSEQLSAVT STHAMEVEKL KKELARYQQN QE.....ADP   979
Hum Myo5c  AWLARRRFQS IRRFVLNIQL TYRVQRLQKK LED..................................QNKENH GLVEKLTSLA ALRAGDVEK. .......... ..........   925
Hum Myo5a  VLSLQEEIAK LRKDLEQTRS EKKCIEEHAD RYKQETEQLV SNLKEENTLL KQEKEALNHR IVQQAKEMTE TMEKKLVEET KQLELDLNDE RLRYQNLLNE FSRLEERYDD  1094
Rat Myo5b  SLQLQEEVQS LRTELQKAHS ERRVLEDAHN RENGELRKRV ADLEHENALL KDEKEHLNHQ ILRQSKAES. ..SQSSVEEN LLIKKELEEE RSRYQNLVKE YSQLEQRYEN  1086
Hum Myo5c  .......IQK LEAELEKAAT HRRNYEEKGK RYRDAVEEKL AKLQKHNSEL ETQKEQIQLK .......... .......... .......... .......... ...LQEKTEE   985
Hum Myo5a  LKEEMTLMVH VPKPGHKRTD STHSS....N ESEYIFSSEI AEMEDIPSRT EEPSEKKVPL DMSLFLKLQK RVTELEQEKQ VMQDELDRKE EQVLRSKAKE EERP..QIRG  1198
Rat Myo5b  LRDEQQ.... ..TPGHRKNP SNQSSLESDS NYPSISTSEI GDTEDALQQV EEIGIEKAAM DMTVFLKLQK RVRELEQERK KLQVQLEKEQ QDSKKVQVEQ QNNGLDVDQD  1190
Hum Myo5c  LKEKMD.... .......... .......... .......... .......... ........NL TKQLFDDVQK E....ERQRM LLEKSFELKT Q......... ..........  1020
Hum Myo5a  AELEYESLKR QELESENKKL KNELNELRKA LSEKSAPEVT APGAP.AYRV LMEQLTSVSE ELDVRKEEVL ILRSQLVSQK EAIQPKDDKN TMTDSTILLE DVQKMKDKGE  1307
Rat Myo5b  ADIAYNSLKR QELESENKKL KNDLNERWKA VADQAMQDNS THSSPDSYSL LLNQLKLANE ELEVRKEEVL ILRTQIMNAD QRRLSGKNME PNINARTSWP NSEKHVDQED  1300
Hum Myo5c  ...DYEK.QI QSLKEEIKAL KDEKMQLQHL VEGE...HVT SDGLKAEVAR LSKQVKTISE .FE...KEIE LLQAQKIDVE KHVQSQKR.. ....EMREKM SEITK....Q  1109
Hum Myo5a  IAQAYIGLKE TNRSSALDYH ELNEDGELWL VYEGLKQANR LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ NLQLPPEARI EASLQHEITR LTNENLYFEE  1417
Rat Myo5b  AIEAYHGVCQ TN.SQTEDWG YLNEDGELGL AYQGLKQVAR LLEAQLQAQN LKHEEEVEHL KAQVEAMKEE MDKQQQTFCQ TLLLSPEAQV EFGVQQEISR LTNENL....  1405
Hum Myo5c  LLESYDIEDV RSRLSVEDLE HLNEDGELWF AYEGLKKATR VLESHFQSQK DCYEKEIEAL NFKVVHLSQE INHLQKLFRE E......NDI NESIRHEVTR LTSENM....  1209
Hum Myo5a  LYADDPKKYQ SYRISLYKRM IDLMEQLEKQ DKTVRK.... .......... .......... .......... .......... .......... .......LKK QLKVFAKKIG  1466
Rat Myo5b  .......... ........DF KELVEKLEKN EK...K.... .......... .......... .......... .......... .......... .......LKK QLKIYMKKVQ  1433
Hum Myo5c  .......... .....MIPDF KQQISELEKQ KQDLEIRLNE QAEKMKGKLE ELSNQLHRSQ EEEGTQRKAL EAQNEIHTKE KEKLIDKIQE MQEASDHLKK QFETESEVKC  1304
Hum Myo5a  ELEV...... .......... ........GQ MENISPGQII DEPIRPVNIP RKEKDFQGML EYKKEDEQKL VKNLILELKP RGVAVNLIPG LPAYILFMCV RHADYLNDDQ  1552
Rat Myo5b  DLEA...... .......... ........AQ ALAQSDRR.H HELTRQVTVQ RKEKDFQGML EYHKEDEALL IRNLVTDLKP QMLS.GTVPC LPAYILYMCI RHADYTNDDL  1517
Hum Myo5c  NFRQEASRLT LENRDLEEEL DMKDRVIKKL QDQVKTLSKT IGKANDVHSS SGPKEYLGML QYKREDEAKL IQNLILDLKP RGVVVNMIPG LPAHILFMCV RYADSLNDAN  1414
           DFEALSY NIYN
Hum Myo5a  KVRSLLTSTI NSIKKVLKKR GDDFETVSFW LSNTCRFLHC LKQYSGEEGF MKHNTSRQNE HCLTNFDLAE YRQVLSDLAI QIYQQLVRVL ENILQPMIVS GMLEHETIQG  1662
Rat Myo5b  KVHSLLSSTI NGIKKVLKKH NEDFEMTSFW LSNTCRLLHC LKQYSGDEGF MTQNTAKQNE HCLKNFDLTE YRQVLSDLSI QIYQQLIKIA EGLLQPMIVS AMLENESIQG  1627
Hum Myo5c  MLKSLMNSTI NGIKQVVKEH LEDFEMLSFW LSNTCHFLNC LKQYSGEEEF MKHNSPQQNK NCLNNFDLSE YRQILSDVAI RIYHQFIIIM EKNIQPIIVP GMLEYESLQG  1524
Hum Myo5a  VSGVKPTGLR KRTSSIAD.E GTYTLDSILR QLNSFHSVMC QHGMDPELIK QVVKQMFYII GAITLNNLLL RKDMCSWSKG MQIRYNVSQL EEWLRDKNLM NSGAKETLEP  1771
Rat Myo5b  LSGVRPTGYR KRSSSMVDGE NSYCLEAIIR QMNFFHTVLC DQGLDPEIIL QVFKQLFYMI NAVTLNNLLL RKDACSWSTG MQLRYNISQL EEWLRGKNLQ QSGAVQTMEP  1737
Hum Myo5c  ISGLKPTGFR KRSSSIDDTD G.YTMTSVLQ QLSYFYTTMC QNGLDPELVR QAVKQLFFLI GAVTLNSLFL RKDMCSCRKG MQIRCNISYL EEWLKDKNLQ NSLAKETLEP  1633
Hum Myo5a  LIQAAQLLQV KKKTDDDAEA ICSMCNALTT AQIVKVLNLY TPVNEFEERV SVSFIRTIQM RLRDRKDSPQ LLMDAKHIFP VTFPFNPSSL ALETIQIPAS LGLGFISRV   1880
Rat Myo5b  LIQAAQLLQL KKKTQEDAEA ICSLCTSLST QQIVKILNLY TPLNGFEERV TVSFIRTIQA QLQERSDPQQ LLLDSKHMFP VLFPFNPSAL TMDSIHIPAC LNLEFLNEV   1846
Hum Myo5c  LSQAAWLLQV KKTTDSDAKE IYERCTSLSA VQIIKILNSY TPIDDFEKRV TPSFVRKVQA LLNSREDSSQ LMLDTKYLFQ VTFPFTPSPH ALEMIQIPSS FKLGFLNRL   1742
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Cell culture and immunofluorescence
Human HeLa cells were obtained as a generous gift of Carol Otey
(University of North Carolina, Chapel Hill, NC) and maintained in
modified Eagle’s medium (MEM) supplemented with 10% fetal
bovine serum and 100 U penicillin-streptomycin. Frozen sections or
cultured cells on coverslips were fixed with 3.7% paraformaldehyde
in PBS for 20 minutes and permeabilized with 0.5% triton X-100 for
10 minutes. Sections or cells were then blocked in 5% goat serum for
~1 hour. All rabbit primary antibodies were used at 5 µg/ml:
nonimmune serum IgG, anti-Myo5a antibody 32a, anti-Myo5c
antibodies 199 and 200 and anti-rab11a (Zymed). Mouse monoclonal
antibodies were used at the following concentrations: anti-rab8 (BD
Transduction Laboratories) at 8 µg/ml; anti-transferrin receptor
(Sigma C-2063) at 1:200; anti-LAMP1 (H4A3, Developmental
Studies Hybridoma Bank) at 10 µg/ml; anti-golgin97 (Molecular
Probes) at 8 µg/ml; anti-mannose-6-phosphate receptor (Affinity
Bioreagents, Inc.) at 8 µg/ml. After incubation in primary antibodies
for ~1 hour, sections or cells were washed 4× in PBS (5 minutes per
wash), incubated with either Alexa 488-conjugated or Alexa 568-
conjugated goat anti-rabbit at 1 µg/ml (Molecular Probes) or TRITC-
conjugated goat anti-mouse at 1:200 (Jackson) secondary antibodies
for ~1 hour, and washed 4× in PBS. Samples to be stained for F-actin
or nuclei were then incubated with rhodamine-phalloidin at 13.2 nM
or 4′,6-diamidine-2′-phenylindole, dihydrochloride (DAPI) at 200 nM
for 15 minutes and washed 3× in PBS. Samples were mounted in
Prolong Antifade media (Molecular Probes) and examined using a
Zeiss fluorescence microscope with a 100× 1.4 NA lens, an Orca-II
cooled CCD camera and Metamorph software. Control images were
obtained and processed under identical conditions.
Transferrin internalization assay
Twenty-four hours after transfection with the GFP-Myo5c tail, HeLa
cells were pre-incubated in serum-free MEM with 0.2% BSA (‘uptake
medium’) for 30 minutes at 37°C, then incubated in uptake medium
containing 25 µg/ml TRITC-transferrin (Molecular Probes) for
10 minutes at 37°C (‘pulse’). After the pulse, cells were fixed
immediately or chased by incubating in unlabeled transferrin for 5,
20, 60 or 120 minutes. To chase, cells were first rinsed three times in
warm uptake medium, then incubated in uptake medium containing
25 µg/ml unlabeled holo-transferrin (Sigma) for the indicated time.
Cells were then rinsed once in cold uptake medium, three times
in cold PBS containing Ca2+ and Mg2+ and then fixed and
immunostained as above.
Online supplemental material
The nucleotide sequence and deduced amino acid translation for
human MYO5C are provided as online supplemental material
(http://jcs.biologists.org/supplemental/).
Results
Discovery of a third member of the myosin-V family in
vertebrates, human Myo5c
Given that class V myosins appear to play crucial roles in cell
function and that Myo5a is abundantly expressed chiefly in
brain and melanocytes, we suspected that non-neuronal cells
might express a novel class V myosin. When the sequence of
rat Myo5b (myr6) was published (Zhao et al., 1996), it became
clear that a small fragment of myosin head domain sequence
(L29144) obtained in our initial PCR screen for unconventional
myosins (Bement et al., 1994) probably represented a third
member of the myosin-V family in human. We thus performed
an extensive analysis of the human EST database and identified
two ESTs that were similar but not identical to the tail domains
of both Myo5a and Myo5b (Fig. 1). Perfect match PCR primers
Fig. 2.Alignment of the three class V myosins in vertebrates. Bolded
letters denote identical residues in all three sequences. The head,
ATP binding site and globular tail are marked. Solid boxes mark each
of six IQ motifs in the neck domain. Regions predicted (Lupas et al.,
1991) to form a coiled-coil with greater than 90% probability are
denoted by dashed underlines. Carets indicate the boundaries of
Myo5a exons A through F that have been mapped by PCR (Lambert
et al., 1998; Seperack et al., 1995), and shading indicates the three
exons known to undergo tissue-specific alternative splicing. Note that
the human Myo5a sequence reported to bind the dynein light chain
(dotted bracket) does not contain exons D and F (Naisbitt et al.,
2000). The sequence corresponding to the mouse Myo5a construct
reported to bind kinesin (Huang et al., 1999) is also indicated (solid
bracket). The position of a conserved serine in the globular tail
(‘serine 1650’ for mouse Myo5a), whose phosphorylation regulates
binding of Myo5a to melanosomes, is marked by a diamond
(Karcher et al., 2001). Rab11a-binding by rabbit Myo5b is reported
to require the sequence corresponding to aa 1397-1418 and 1797-
1811 of rat Myo5b (Lapierre et al., 2001). The sequence and location
of a putative vacuole-binding site in the globular tail of Myo2p is
also shown; asterisks denote functionally crucial residues (Catlett et
al., 2000). The GenBank accession number for Myo5c is AF272390.
Fig. 3. The relative mRNA distribution
of the class V myosins in northern and
dot blots shows that Myo5a is most
abundantly expressed in brain, whereas
Myo5b and Myo5c have a broad
distribution. Myo5c is particularly
abundant in secretory or epithelial
tissues. Human mRNA blots (Clontech)
were hybridized to probes for Myo5a,
Myo5c and Myo5c. Subsequent
incubations with control probes
(ubiquitin or β-actin) revealed that the
mRNA loadings were in fact well
normalized (not shown). 
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to these head and tail fragments were then used to clone a ~4.8
kb PCR product (Clone 7) from pancreas cDNA; this clone,
together with a PCR clone containing 5′ sequence (Clone 5),
includes the full-length coding sequence of a novel member of
the myosin-V family we have named myosin-Vc (Figs 1, 2)
(see also http://jcs.biologists.org/supplemental/). 
Analysis of the now completed human genome indicates that
Myo5c is the third and final member of its class (Berg et al.,
2001). Analysis of genomic sequence also indicates that the
human MYO5Cgene has ~39 exons and extends over ~100 kb.
Interestingly, the human MYO5A gene is located at 15q21
immediately adjacent (within 18 kb) to the 3′ end of the
MYO5A gene. The Myo5a/dilute locus has been well
characterized in mouse, and several other lethal mutations are
known to lie near this locus (Rinchik et al., 1986). If mouse
and human maintain synteny in this area, then the mouse
Myo5cgene is likely to reside on chromosome 9 in the ~300
kb region between the dilute and short earmutations. There
are two known lethal mutations in this region and, on the basis
of its position, neonatal-lethal 2 is a good candidate to
correspond to mouse Myo5c.
Myo5c shares only ~50% identity with Myo5a and
Myo5b but has a generally similar structure
The deduced sequence of human MYO5C consists of 1742
amino acids (aa) encoding a 203 kDa heavy chain sharing
~50% overall identity with human or mouse Myo5a and rat
Myo5b (Fig. 1B,C). Residues 1-753 encode a class V myosin
motor domain sharing 68% identity with those of Myo5a and
Myo5b. As expected for a class V myosin, Myo5c contains six
IQ motifs and would thus be predicted to have as many as six
calmodulin or calmodulin-like light chains (Espreafico et al.,
1992). Following the sixth IQ motif are 411 aa predicted to
form several segments of coiled-coil (Figs 1, 2). The coiled-
coil regions share only 20-30% identity with the corresponding
regions of Myo5a and Myo5b; in this same region, Myo5a and
Myo5b share 42% identity. Myo5c entirely lacks the PEST
region that interrupts the coiled-coil in Myo5a and Myo5b; in
Myo5a this is a site of in vitro cleavage by the calcium-
dependent protease calpain (Nascimento et al., 1996). Due in
part to its lack of a PEST site, Myo5c is ~12 kDa smaller than
Myo5a or Myo5b. The coiled-coil in Myo5c is interrupted by
a ~40 aa region that shares similarity with portions of the ~112
aa non-coiled-coil region found in Myo5a and Myo5b. This
similarity extends to exon D of Myo5a, which is a 26 aa exon
expressed in melanocyte but not brain Myo5a (Lambert et al.,
1998; Seperack et al., 1995). The C-terminal 392 aa of Myo5c
share ~60% identity with the globular tails of Myo5a and
Myo5b. The conserved globular tail of the class V myosins has
been implicated in binding to cargos such as melanosomes
(Wu et al., 1998), secretory vesicles (Schott et al., 1999) and
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Fig. 4. Myo5c protein is abundant in
epithelial and secretory tissue.
(A) Immunoblot showing the protein
distribution of class V myosins in
mouse tissues. Myo5a is abundant in
brain, whereas Myo5b and Myo5c are
more widely distributed in non-
neuronal tissues. Gels were run in
triplicate, samples were loaded
equally by wet tissue weight and
blots were probed with antibodies to
Myo5a, Myo5b or Myo5c. It is
unclear if the lower band detected by
the Myo5b antibodies in brain
represents a breakdown product.
(B) Immunoblot showing that Myo5c
is enriched in the mucosa of mouse
colon, but not the underlying muscle
wall. The Ponceau stain of this blot
shows that myosin-II and actin are
found primarily with the muscle wall.
The mucosa was dissected from 0.4 g
of colon by scraping. The mucosal
layer and the muscle wall were then
separately homogenized in 4 ml of
buffer as for the other mouse tissue
homogenates, and equal volumes
were loaded. (C) Immunblots of
untransfected and transfected Hela
cells. Blotting of HeLa cell lysates
reveals that these cells endogenously
express both Myo5a and Myo5c (left
panels, 50 µg load). HeLa cells
transfected with the GFP-Myo5c tail
express a protein of the expected size,
~120 kDa (right panels, 20 µg load).
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vacuoles (Catlett et al., 2000), and to proteins such as Smy1p
(Lillie and Brown, 1998), kinesin (Huang et al., 1999) and
rab11a (Lapierre et al., 2001). Interestingly, all three of the
class V myosins in vertebrates contain a conserved serine
whose phosphorylation in Myo5a regulates its binding to
melanosomes (‘serine 1650’ of mouse Myo5a) (Karcher et al.,
2001). 
Myo5c is widely distributed in secretory and epithelial
tissue
To systematically determine the expression patterns of the
three class V myosins in vertebrate tissues, we first analyzed
the distributions of their mRNAs. A northern blot and a dot
blot (Fig. 3) containing mRNA samples from many human
tissues were hybridized under high stringency conditions with
probes for human Myo5a, Myo5b and Myo5c. As expected
from previous analyses (Espreafico et al., 1992; Mercer et al.,
1991), Myo5a mRNA (~8 and 12 kb) is most abundant in brain
and is expressed at lower levels in other tissues. The Myo5b
mRNA (7 kb) has a broader distribution and is relatively
abundant in kidney, liver and placenta, with little or no signal
detected in brain. Most importantly, we found that the Myo5c
mRNA (8.7 kb) has a broad distribution and is expressed in
epithelial and glandular tissues such as salivary, stomach,
colon, pancreas, lung, thyroid, prostate and mammary.
To determine the protein distribution of class V myosins, we
first generated specific antibodies to Myo5b and Myo5c. We
then probed immunoblots of mouse tissues and a human cell
line with these antibodies and our existing Myo5a antibodies
(Fig. 4A-C). As expected, Myo5a protein is most abundant in
brain, with little or no protein detected in the other tissues
tested (Fig. 4A). By contrast, Myo5b and Myo5c are easily
detected in many non-neuronal tissues. Myo5b is most
abundant in kidney, whereas Myo5c is especially abundant in
pancreas, colon and stomach (Fig. 4A). These different patterns
of distribution also provide strong evidence that our antibodies
are specific. The slightly smaller size of the band recognized
by the Myo5c antibodies (most obvious in samples blotted side
by side, as in Fig. 4C) also indicates that the Myo5c antibodies
do not react with Myo5a or Myo5b. On the basis of the use of
immunoprecipitated Myo5c as a standard in western blots, we
estimate that Myo5c constitutes ~0.02% of the total protein in
mouse stomach. To determine whether Myo5c associates with
the mucosa or the underlying muscle wall in tissues such as
mouse colon, we isolated the mucosa from the wall by scraping
Fig. 5.Myo5c is expressed in epithelial
cells of the colon and pancreas. In human
colon sections double-labeled for Myo5c
(A) and F-actin (B), Myo5c localizes to the
single layer of epithelial cells constituting
the intestinal crypts, as seen in longitudinal
section (arrow) and cross section
(arrowhead). Myo5c is particularly
enriched in the apical portion of the
epithelial cells, where it colocalizes with F-
actin. The basolateral portions of these
cells, which extend ~30 µm, exhibit some
Myo5c staining but relatively little F-actin
staining. The surrounding interstitial cells
are faintly stained by F-actin but exhibit
little or no Myo5c staining and appear
black. (C) Non-immune serum IgG exhibits
little or no staining of the adjacent section.
(D) Higher magnification view of a single
crypt showing Myo5c staining of individual
intestinal epithelial cells. These cells,
which surround the intestinal lumen,
exhibit bright apical staining and fainter
staining of cytoplasm and lateral cell
margins. (E) In mouse pancreas sections,
Myo5c localizes to the exocrine pancreas.
(F,G) Higher magnification of the same
section, triple-labeled for Myo5c (green),
F-actin (red) and DAPI to label nuclei
(blue), shows that Myo5c colocalizes with
F-actin in the apical portions (arrows, F,G)
of epithelial cells. Note that Myo5c does
not colocalize with all F-actin-containing
structures (arrowheads, F,G). 
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Fig. 6. Overexpressing the GFP-
Myo5c tail leads to the formation
of puncta and tubulovesicular
structures. In transfected cells,
the GFP-Myo5c tail forms
puncta and tubules (A,B,D,G),
suggestive of a membranous
compartment, whereas GFP
alone has a diffuse distribution
(C). (D-F) Antibodies to Myo5c
stain the puncta. (G-I) The
puncta formed by overexpression
of the GFP-Myo5c tail do not
colocalize with endogenous
Myo5a, which shows a striking
localization to small puncta in
the periphery of the cell.
Fig. 7.The GFP-Myo5c tail
does not colocalize with or
perturb the Golgi compartment,
late endosomes or lysosomes.
Arrows denote cells expressing
the GFP-Myo5c tail, whereas
arrowheads mark untransfected
cells. (A-C) The GFP-Myo5c
tail does not colocalize with
golgin97, a membrane marker
for the Golgi compartment. (D-
F) Although the mannose-6-
phosphate receptor cycles
between the TGN, late
endosomes, and lysosomes, at
steady state the majority of the
receptor is found on late
endosomes, where it does not
colocalize with the GFP-Myo5c
tail. (G-I) The GFP-Myo5c tail
also fails to colocalize with
LAMP1, a membrane marker for
lysosomes.
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and blotted the resulting fractions with Myo5c antibodies (Fig.
4B). Although most of the actin and conventional myosin
remained with the muscle wall, virtually all of the Myo5c was
found in the mucosal fraction containing the intestinal
epithelial cells. Immunoblotting also indicates that endogenous
Myo5a and Myo5c are present in HeLa cells, a cell line derived
from a human cervical carcinoma (Fig. 4C, left panels).
Myo5c localizes to epithelial cells of the colon and
pancreas
To determine which types of cells express Myo5c, we stained
human colon sections for Myo5c and found that it localizes to
the single layer of epithelial cells lining the colonic crypts (Fig.
5A). Double-labeling with F-actin revealed that Myo5c is
particularly prominent in the F-actin-rich apical regions of the
intestinal epithelial cells (Fig. 5B). Non-immune antibodies
showed little or no staining (Fig. 5C). Higher magnification
showing individual epithelial cells reveals that Myo5c is
present in both the apical and basolateral regions, but is not
detected in the surrounding interstitial cells.
In mouse pancreas, Myo5c localizes to the exocrine
pancreas rather than the islets of the endocrine pancreas (Fig.
5E). Higher magnification of triple-labeled sections shows that
Myo5c (Fig. 5F, green) largely overlaps with apical F-actin
(Fig. 5G, red) in epithelial cells of the exocrine pancreas. It is
not yet clear whether Myo5c localizes to the acinar cells,
centroacinar cells, or both. Taken together, the evidence from
northern blotting, immunoblotting and immunolocalization
clearly indicates that Myo5c is a broadly distributed class V
myosin that is especially abundant in epithelial cells.
Localization and dominant negative effects of the GFP-
Myo5c tail
If Myo5c functions in organelle transport, overexpressing its
tail domain should saturate the binding sites for the
endogenous motor and thus inhibit its function. This dominant
negative strategy has been very successful with other class V
myosins, including Myo2p (Catlett et al., 2000; Reck-Peterson
et al., 1999; Schott et al., 1999), Myo5a (Rogers et al., 1999;
Wu et al., 1998) and Myo5b (Lapierre et al., 2001), as well as
for class I myosins (Durrbach et al., 2000; Raposo et al., 1999).
In these studies, overexpression of a tail construct led to an
accumulation or altered distribution of a specific set of
organelles, presumably due to failure of the organelle to be
transported or anchored to its normal location. We thus
generated a dominant negative construct consisting of GFP
fused to the entire tail of Myo5c (Fig. 1A). We used HeLa cells
for our dominant negative studies because they are easily
transfected and their membrane trafficking pathways are
relatively well characterized. Immunoblots show that HeLa
cells express low levels of endogenous Myo5a and Myo5c and
that cells transfected with the GFP-Myo5c tail express a
protein of the expected size (Fig. 4C). On the basis of a
transfection efficiency of ~20-50%, we estimate that the GFP-
Myo5c tail is overexpressed on the order of 100-fold relative
to endogenous Myo5c. 
Fig. 8. The overexpressed GFP-
Myo5c tail colocalizes with and
perturbs a compartment
containing the transferrin receptor
and rab8, but not rab11a. In all
panels, arrows denote transfected
cells and arrowheads denote
untransfected cells. (A-C) The
overexpressed GFP-Myo5c tail
colocalizes with the transferrin
receptor, a marker for the
endosomal pathway. Furthermore,
the distribution of the transferrin
receptor is perturbed in cells
expressing the GFP-Myo5c tail
(arrows) as compared to
untransfected cells (arrowheads).
(D-I) Transfected cells were also
stained for rab proteins to define
specific membrane
compartments. The GFP-Myo5c
tail puncta colocalize with rab8
(D-F), but not rab11a (G-I).
Similar to the results with the
transferrin receptor, at least some
of the rab8 distribution appears
perturbed in transfected cells
(arrow, F), whereas the
distribution of rab11a does not
appear to be significantly altered




Overexpressing the GFP-Myo5c tail in HeLa cells leads to
the formation of numerous bright ‘puncta’ distributed
throughout the cell and less frequently to tubulovesicular
structures (Fig. 6A,B,D,G). Transfection with GFP alone
yields only diffuse cytoplasmic staining (Fig. 6C). The
localization of the GFP-Myo5c tail to puncta and structures
with a tubulovesicular appearance suggests that it is associated
with a membranous compartment. Although our current
Myo5c antibodies appear unsuitable for immunofluorescent
localization of the low levels of endogenous Myo5c present in
HeLa cells, these antibodies do stain the puncta constituted by
the GFP-Myo5c tail (Fig. 6D-F). Non-immune antibodies do
not detect the puncta (not shown). Interestingly, staining with
our Myo5a antibodies reveals that the endogenous HeLa cell
Myo5a exhibits a striking localization to peripheral puncta
(Fig. 6G-I). It is important to note that the GFP-Myo5c tail
does not colocalize with this endogenous Myo5a compartment
and does not perturb its distribution. It is also important to note
that the formation of the GFP-Myo5c puncta is not exclusive
to HeLa cells; we observe similar puncta when we express the
GFP-Myo5c tail in HEK 293 cells, 3T3 cell or polarized LLC-
PK1 cells (not shown).
The GFP-Myo5c tail colocalizes with and perturbs the
distribution of a compartment containing the transferrin
receptor 
To identify the compartment associated with the GFP-Myo5c
tail, we transiently transfected cells and then used
immunofluorescence to determine if the GFP-Myo5c tail
colocalizes with markers for well-characterized membrane
compartments. The GFP-Myo5c tail does not colocalize with
markers for the Golgi compartment (golgin97, Fig. 7A-C), late
endosomes (mannose-6-phosphate receptor, Fig. 7D-F) or
lysosomes (LAMP1, Fig. 7G-I). In addition, the GFP-Myo5c
tail does not noticeably perturb the organization or distribution
of these compartments. The GFP-Myo5c tail puncta do not
appear to be aggresomes (Kopito, 2000) as they fail to
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Fig. 9. In cells expressing the
GFP-Myo5c tail, transferrin is
taken up normally and
colocalizes with the Myo5c tail
after a short delay, but transferrin
trafficking is inhibited. Cells
were incubated in TRITC-
transferrin for 10 minutes,
followed by incubation in
unlabeled transferrin for various
‘chase’ times of 0, 5, 20 or 60
minutes. (A-C) Cells expressing
the GFP-Myo5c tail (arrows)
appear to internalize transferrin
similar to untransfected cells
(arrowhead). After 10 minutes of
internalization, transferrin does
not significantly colocalize with
the GFP-Myo5c tail puncta, but
by 20-60 minutes (D-I),
transferrin shows obvious
colocalization with the GFP-
Myo5c tail. Furthermore,
transferrin remains in cells
expressing the GFP-Myo5c tail
(arrows) for much longer than in
untransfected cells (arrowheads),
indicating that the GFP-Myo5c
tail impedes transferrin
trafficking. (J-K) Close
examination of cells after 5
minutes of chase, when
transferrin first begins to
colocalize with the GFP-Myo5c
tail, reveals that transferrin
appears to associate with the
margins of the GFP-Myo5c tail
puncta (arrows). 
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colocalize with aggresome markers such as vimentin baskets
or hsc70 (not shown). 
The GFP-Myo5c tail does exhibit striking colocalization
with the transferrin receptor, an integral membrane protein
frequently used as a marker for the endosomal pathway (Fig.
8A-C). Furthermore, the distribution of the transferrin receptor
is dramatically perturbed in cells expressing the GFP-Myo5c
tail. Although virtually all of the GFP-Myo5c tail puncta
colocalize with the transferrin receptor, note that some of the
transferrin receptor-containing membranes do not colocalize
with the GFP-Myo5c tail and do not appear to be obviously
perturbed by it. The GFP-Myo5c tail thus specifically
colocalizes with a subset of membranous organelles that
contain the transferrin receptor. 
The GFP-Myo5c tail colocalizes with and perturbs the
distribution of Rab8 but not Rab11a
Because the class V myosin Myo2p and the rab protein Sec4p
exhibit genetic interactions and are essential for polarized
secretion in yeast (Finger and Novick, 2000), we asked if the
GFP-Myo5c tail colocalizes with rab8, one of the vertebrate
rab proteins most similar to Sec4p (Chavrier et al., 1990). Rab8
is also a ubiquitously expressed rab originally implicated in
regulating transport of basolaterally targeted proteins from the
TGN to the plasma membrane (Huber et al., 1993a; Huber et
al., 1993b). As shown in Fig. 8D-F, some rab8 clearly
colocalizes with and is perturbed by the GFP-Myo5c tail.
Given that a GFP-Myo5b tail construct has recently been
shown to colocalize with and perturb a recycling compartment
containing the transferrin receptor and rab11a in HeLa cells
(Lapierre et al., 2001), we also asked if the GFP-Myo5c tail
colocalizes with rab11a. As shown in Fig. 8G-I, the GFP-
Myo5c tail does not colocalize with or perturb rab11a. This
indicates that the compartment associated with the GFP-
Myo5c tail and rab8 is distinct from the rab11a compartment
associated with the GFP-Myo5b tail. The GFP-Myo5c tail also
failed to colocalize with rab4, although it should be noted that
both of the rab4 antibodies that we used yielded only faint
staining (not shown). In summary, the GFP-Myo5c tail
selectively perturbs a compartment containing transferrin
receptors and rab8, but not rab11a.
Overexpressing the GFP-Myo5c tail perturbs transferrin
trafficking
To investigate whether the Myo5c tail perturbs a secretory
pathway (as might be expected from its association with rab8)
or an endosomal pathway (as might be expected from its
association with transferrin receptor), we next performed
pulse-chase experiments with TRITC-labeled transferrin. In
this experiment, HeLa cells were incubated (pulsed) with
TRITC-labeled transferrin for 10 minutes and then chased
through the endocytic and recycling pathways by incubating
in unlabeled transferrin for 0, 5, 20, 60 or 120 minutes. In
cells that were pulsed and fixed without chasing, TRITC-
transferrin was internalized normally in both transfected and
untransfected cells (Fig. 9A-C). Thus, expression of GFP-
Myo5c tail does not grossly impair endocytosis of transferrin.
At this early time point, when transferrin is known to be
passing through the early endosomal pathway (Yamashiro
et al., 1984), there is no colocalization with the GFP-Myo5c
tail. 
When the cells are chased with unlabeled transferrin for 5
minutes, TRITC-transferrin begins to colocalize with the GFP-
Myo5c tail puncta. After 20 minutes of chase, much of the
TRITC-transferrin obviously colocalizes with the GFP-Myo5c
tail puncta (arrow, Fig. 9D-F). In cells expressing the GFP-
Myo5c tail, some TRITC-transferrin remains colocalized with
the GFP-Myo5c tail puncta at 60 (Fig. 9G-I) and 120 minutes
(not shown), long after the TRITC-transferrin in untransfected
cells has recycled back to the plasma membrane. Thus,
overexpressing the GFP-Myo5c tail either blocks or greatly
delays the recycling of transferrin back to the plasma
membrane. These experiments reveal that the GFP-Myo5c tail
labels a compartment accessible to transferrin, and that
overexpressing the GFP-Myo5c tail perturbs the trafficking of
at least some transferrin.
Interestingly, the internalized TRITC-transferrin initially
a pears to associate with the edges of the GFP-Myo5c tail
puncta (Fig. 9J,K), as if newly arrived vesicles are adding to
an existing clump of vesicles. To summarize, cells
overexpressing the GFP-Myo5c tail appear to endocytose
transferrin similarly to untransfected cells. After a short delay,
transferrin exhibits clear colocalization with the GFP-Myo5c
tail in a compartment that appears to be downstream of the
arly endosome. Lastly, the GFP-Myo5c tail appears to inhibit
the recycling of at least some transferrin to the surface. 
Discussion
We report here the discovery of a new member of the myosin-
V family, human Myo5c. Our analysis reveals that Myo5c is a
broadly expressed class V myosin that is especially abundant
in tissues with prominent secretory or epithelial functions such
as exocrine pancreas, prostate and mammary gland.
Immunofluorescence localization shows that Myo5c is
expressed at the highest levels in epithelial cells. A dominant
negative strategy using overexpression of the GFP-Myo5c tail
in HeLa cells indicates that it selectively associates with and
perturbs a specific membrane compartment that contains
transferrin receptor and is accessible to transferrin. This
compartment colocalizes with rab8 but not rab11a, and thus
appears to be distinct from the recycling compartment recently
associated with Myo5b and rab11a (Lapierre et al., 2001). 
What are the relative roles of the three class V myosins
in vertebrates?
The presence of three class V myosins in vertebrates raises
several obvious questions. Does a given cell express only one
class V myosin or all three? Do class V myosins generally
function in the actin-rich cortex to move organelles towards the
plasma membrane? Are these myosins found on the same
organelle or do they each associate with a specific organelle or
set of organelles? Given that Myo5a is expressed at high levels
chiefly in brain and melanocytes, do Myo5b and Myo5c
underlie actin-based organelle transport in most other cells and
tissues? Although fully answering these and related questions
will require much additional research, the systematic analysis
of the class V myosins presented here allows us to tentatively
answer some of these questions. We find that HeLa cells
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express low levels of both Myo5a and Myo5c and the work of
Lapierre et al. (Lapierre et al., 2001) suggests that HeLa cells
also express Myo5b. In preliminary immunoblotting
experiments we find that Myo5a and Myo5c are both detected
in several cell lines including HEK 293, Hs766T, LLC-PK1,
Caco-2 and MDCK cells. This shows that several cell types
express multiple class V myosins. Although Myo5a is most
abundant in neurons, neurosecretory cells and melanocytes,
work from our lab and many others indicates that low levels of
Myo5a are detected in most cell types. Given the relatively
broad tissue distribution that we observe for Myo5b and
Myo5c, it is likely that many cells express multiple class V
myosins, with the relative levels of expression varying greatly
among different cell types. 
Although we do not yet know the precise numbers of
molecules of Myo5a, Myo5b and Myo5c expressed in various
kinds of cells, we do know that Myo5a levels, like those of
kinesin, correspond to ~0.2% of total protein in brain (Cheney
et al., 1993). We find that Myo5c is expressed in many tissues
and is most abundantly expressed in epithelial cells. Given that
Myo5c constitutes ~0.02% of total protein in stomach (of
which epithelial cells constitute only a fraction) and that tissues
such as pancreas and prostate express several-fold higher levels
of Myo5c, it is likely that the abundance of Myo5c in some
epithelial cells approaches that of Myo5a in brain. Myo5c is
thus a major class V myosin of at least some epithelial cells
and would be expected to play an important role in the
physiological functions of these cells. Current work is thus
directed at determining whether the Myo5cgene is required for
survival, as might be suggested by the location of the neonatal
lethal-2deletion in mouse.
Although there is still a great deal of uncertainty about the
precise functions of the class V myosin and the identity of their
cargoes, Myo5a is clearly associated with the trafficking of
melansomes in melanocytes (Rogers et al., 1999; Wu et al.,
1998) and the trafficking of an inositol triphosphate receptor-
containing compartment in neurons (Takagishi et al., 1996).
Myo5b has recently been implicated in the function of a
rab11a-associated recycling endosome in HeLa cells and in a
rab11a-associated recycling compartment required for
transcytosis in polarized MDCK cells (Lapierre et al., 2001).
As discussed below, our data implicate Myo5c in the function
of a transferrin-accessible compartment in HeLa cells that
appears to be distinct from the Myo5b/rab11a recycling
compartment as well as the endogenous Myo5a compartment.
Taken together, these data strongly suggest that each of the
class V myosins is associated with a specific set of membrane
trafficking events. It will thus be important to determine
whether the variation in the expression levels of the class V
myosins observed between cells such as Myo5a-rich neurons
and Myo5c-rich epithelial cells corresponds with the
elaboration of specific membrane trafficking pathways. In this
regard it is interesting to note that Drosophila (and
Caenorhabditis elegans) expresses only a single class V
myosin that is equally related to each of the three vertebrate
class V myosins.
What compartment is the Myo5c tail associated with?
We hypothesize that the GFP-Myo5c tail acts as a dominant
negative by displacing endogenous Myo5c from its tail-
associated cargos. Because the GFP-Myo5c tail includes the
coiled-coil portion of the tail, this construct might also
suppress the function of endogenous Myo5c by dimerizing
with it, thus forming dimers with only one motor domain. In
either case, our dominant negative approach appears to be
highly specific as it does not obviously perturb the Golgi
compartment, late endosomes, lysosomes, endogenous Myo5a
or the rab11a-associated recycling compartment. The dominant
negative studies with the GFP-Myo5c tail reported here also
provide strong evidence that the Myo5c tail associates with a
membranous compartment. This evidence includes: (1)
localization to structures with a punctate or tubulovesicular
appearance; (2) colocalization with transferrin receptor, an
integral membrane protein; (3) colocalization with a specific
rab protein; and (4) colocalization with transferrin, a lumenal
marker for membranes involved in endosomal/recycling
pathways. 
Our results showing that the Myo5c tail colocalizes with and
perturbs the distribution of the transferrin receptor and rab8 in
HeLa cells share some striking similarities to recent work with
Myo5b (Lapierre et al., 2001). Lapierre et al. (Lapierre et al.,
2001) discovered that overexpression of the GFP-Myo5b tail
in HeLa cells results in the elaboration of a compartment
containing the transferrin receptor, the Myo5b tail, and rab11a.
As a control for specificity, these investigators showed that an
analogous GFP-Myo5a tail construct failed to colocalize with
the transferrin receptor or alter its distribution. In support of
these data showing that the tails of the class V myosins exhibit
highly specific targeting, we find that the GFP-Myo5c tail does
not colocalize with or perturb the distribution of endogenous
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Fig. 10. A working model of class V myosins in membrane
trafficking in HeLa cells. Myo5a exhibits a striking localization to
small puncta of an unknown identity in the periphery. In HeLa cells
Myo5b appears to associate with a major recycling compartment
containing rab11a, as a dominant negative construct consisting of the
Myo5b tail inhibits transferrin recycling and colocalizes with the
transferrin receptor and rab11a (Lapierre et al., 2001). By contrast,
the Myo5c tail associates with an apparently distinct transferrin-
accessible compartment containing rab8 but not rab11a. Although
the precise nature of the pathway associated with Myo5c in HeLa
cells is unclear, this pathway is likely to be of particular importance
in the epithelial cells where this myosin is most abundantly
expressed.
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Myo5a. More importantly, given that our overexpression
experiments with the GFP-Myo5c tail in HeLa cells show no
evidence of colocalization with rab11a, Myo5c appears to be
associated with a different membrane compartment than
Myo5b. It also appears that there are morphological differences
between these two compartments as the puncta formed by the
GFP-Myo5b tail are relatively large and centrally located
(Lapierre et al., 2001), whereas the puncta we observe with the
GFP-Myo5c tail are smaller, more numerous and located
throughout the cell. 
Our current working model of the roles of the class V
myosins in membrane trafficking in HeLa cells is illustrated
in Fig. 10. Although Myo5a is expressed at only low levels in
HeLa cells, it exhibits an intriguing punctate localization in
the periphery of the cell. Although the precise identity of this
compartment is unknown, it does not appear to be endosomal
as it fails to colocalize with the transferrin receptor (not
shown). On the basis of use of a GFP-Myo5b tail construct,
Myo5b in HeLa cells is reported to associate with a recycling
endosome containing the transferrin receptor and rab11a
(Lapierre et al., 2001). Furthermore, overexpressing the
Myo5b tail led to an accumulation of transferrin in this
compartment and blocked the recycling of transferrin back to
the plasma membrane. Our work in HeLa cells indicates that
the Myo5c tail associates with a compartment containing the
transferrin receptor and rab8. Overexpressing the GFP-Myo5c
tail also leads to an accumulation of transferrin and perturbs
transferrin trafficking. Because this Myo5c-associated
compartment does not contain rab11a, it appears to be distinct
from the recycling compartment associated with Myo5b.
Although Myo5b appears to play a major role in transferrin
recycling in HeLa cells, in polarized MDCK cells it seems to
be involved in transcytosis rather than transferrin recycling
(Lapierre et al., 2001). We thus suggest that Myo5c functions
in a pathway different from that of Myo5b and that this
pathway is likely to be of particular importance in the
polarized epithelial cells where Myo5c is most abundantly
expressed. 
The colocalization of the GFP-Myo5c tail with rab8 is
intriguing, given that rab8 may be the vertebrate homolog of
Sec4p (Chavrier et al., 1990). This raises the exciting
possibility that Myo5c and rab8 have a role in vertebrate
epithelial cells analogous to the role of Myo2p and Sec4p in
polarized secretion in yeast. Some caution is warranted here,
however. First, we have only used rab8 as a compartment
marker, and have no evidence that it directly interacts with
Myo5c. Second, the accumulation of rab8 that we observe (as
well as the accumulation of transferrin) could be due to
blockade of a membrane trafficking event that occurs
downstream of the usual sites of action of rab8. Third, rab8
was originally implicated in regulating the secretory pathway
transporting proteins from the TGN to the basolateral plasma
membrane (Huber et al., 1993a; Huber et al., 1993b), whereas
our localization data indicate that Myo5c is most prominent in
the apical portions of epithelial cells. Although there are many
possible explanations for this apparent discrepancy, one
possibility is that rab8 may have functions in addition to its
role in regulating traffic to the basolateral plasma membrane.
In fibroblasts rab8 appears to play only a minor role in
regulating transport of proteins to the plasma membrane (Chen
et al., 1998; Peranen et al., 1996) and one study suggests that
rab8 is associated with the promotion of organelle transport via
reorganization of the actin and microtubule cytoskeleton
(Peranen et al., 1996). Testing Myo5c for the ability to interact
with rab proteins and characterizing the compartments
associated with endogenous Myo5c in polarized and
unpolarized cells will obviously be important steps in resolving
these issues.
Although our data implicate Myo5c in membrane
trafficking, the precise identity of the compartment(s) involved
remains unknown, as does the precise stage at which Myo5c
functions. Although class V myosins might be expected to
function in the transport of shuttle vesicles to targets such as
the plasma membrane (with the transport complex defined by
the presence of an active motor), they could be involved in
other essential trafficking processes such as budding, tethering
or fusion. In this regard it will be interesting to examine the
EM appearance of the puncta induced by overexpressing the
GFP-Myo5c tail to determine if they consist of an aggregate of
small vesicles. In preliminary live-cell imaging experiments we
find that a subset of the small puncta labeled by the GFP-
Myo5c tail shortly after transfection undergo linear movements
over distances of at least 5-10 µm. This suggests that at least
some of the structures associated with the GFP-Myo5c tail at
these early times undergo motor-driven movement.
In conclusion, we report the discovery of the third and final
member of the myosin V family in vertebrates. Myo5c is
present in many tissues and appears to be a major class V
myosin of epithelial cells. Overexpressing the GFP-Myo5c tail
in HeLa cells leads to colocalization with the transferrin
receptor and rab8, and also perturbs transferrin trafficking.
Because class V myosins appear to function as motors for
organelle trafficking, the dominant negative strategy used here
provides a powerful approach to selectively inhibit the
function of a specific unconventional myosin and thus
delineate the molecular basis of actin-dependent organelle
transport. The discovery of Myo5c also represents an
important opportunity to extend studies of the class V myosins
beyond useful model systems such as yeast and melanocytes
to include many of the physiologically crucial tissues and cells
of the human body.
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